Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Lu, Xinyan
Professor
Bio
My current clinical research focuses on the genetics/genomics in multiple myeloma, leukemias and solid tumors.
Luchtel, Rebecca A
Research Assistant Professor
Bio
My work is focused on improving our understanding of epigenetic and transcriptional regulation mechanisms contributing to tumor development, tumor-immune cell interactions, and response to therapy. My... [more]
Lukas, Rimas
Associate Prrofessor
Bio
My research interests focus on primary brain tumors as well as central nervous system metastases. I also have a strong interest in clinical neuroscience education and participates in medical education... [more]